Andrew Doan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

African American

Health Insurance

Top Venues

Pediatric blood & cancer

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra Elizabeth Kovach, Maximilian Wengyn, My H Vu, Andrew Doan, Gordana Raca, Deepa Bhojwani
IKZF1 PLUS alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemia. Pediatric blood & cancer 71 (7) (2024)
Alexandra Elizabeth Kovach, Maximilian Wengyn, My H Vu, Andrew Doan, Gordana Raca, Deepa Bhojwani
IKZF1 PLUS alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemia. Pediatric blood & cancer 71 (7) (2024)
Alexandra Elizabeth Kovach, Maximilian Wengyn, My H Vu, Andrew Doan, Gordana Raca, Deepa Bhojwani
IKZF1 PLUS alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemia. Pediatric blood & cancer (2024)
Alexandra Elizabeth Kovach, Maximilian Wengyn, My H Vu, Andrew Doan, Gordana Raca, Deepa Bhojwani
IKZF1 PLUS alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemia. Pediatric blood & cancer (2024)
Alexandra Elizabeth Kovach, Maximilian Wengyn, My H Vu, Andrew Doan, Gordana Raca, Deepa Bhojwani
IKZF1 PLUS alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemia. Pediatric blood & cancer 71 (7) (2024)
Andrew Doan, Holly K T Huang, Ari J Hadar, Jemily Malvar, Teresa Rushing, Gordana Raca, Alexandra E Kovach, David R Freyer, Chintan Parekh, Jamie Stokke, Leila C Posch, Julie Dao, Deepa Bhojwani, Paul Gaynon, Etan Orgel
Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia population. British journal of haematology (2023)
Andrew Doan, Holly K T Huang, Ari J Hadar, Jemily Malvar, Teresa Rushing, Gordana Raca, Alexandra E Kovach, David R Freyer, Chintan Parekh, Jamie Stokke, Leila C Posch, Julie Dao, Deepa Bhojwani, Paul Gaynon, Etan Orgel
Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia population. British journal of haematology (2023)
Sebastian de Armas, Carolina Huertas-Ayala, Randall Y Chan, Yueh-Yun Chi, Winston W Huh, Amanda Termuhlen, Paul S Gaynon, Alexandra E Kovach, Andrew Doan
Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution. Pediatric blood & cancer 69 (5) (2022)
Eric S Schafer, Karen Chao, Alexandra M Stevens, Eunji Jo, Susan G Hilsenbeck, Nathan P Gossai, Andrew Doan, Susan I Colace, Terri Guinipero, Daniel Otterson, Joel A Kaplan, Ashley Hinson, Lauren Pommert, Alan S Wayne, Deepa Bhojwani, Michael J Burke
Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatric blood & cancer 69 (10) (2022)